Research/art/teacher profile of a person
Name and surname:
MUDr. Kristína Simon Klenovics, PhD.
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Simon Klenovics
I.2 - Name
Kristína
I.3 - Degrees
MD., PhD.
I.4 - Year of birth
1980
I.5 - Name of the workplace
Institute od physiology, Faculty of medicine, Comenius university, Bratislava
I.6 - Address of the workplace
Dean´s office, Špitálska 24, 813 72 Bratislava
I.7 - Position
university lecturer - scientific advisor
I.8 - E-mail address
kristina.simon.klenovics@fmed.uniba.sk
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.portalvs.sk/regzam/detail/5928
I.10 - Name of the study field in which a person works at the university
Physiology

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.2 - Second degree of higher education
II.a - Name of the university or institution
Faculty of Medicine, Comenius university, Bratislava
II.b - Year
2005
II.c - Study field and programme
general medicine
II.3 - Third degree of higher education
II.a - Name of the university or institution
Faculty of Medicine, Comenius university, Bratislava
II.b - Year
2011
II.c - Study field and programme
Pediatrics
II.4 - Associate professor
II.5 - Professor
II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
Faculty of Medicine, Comenius university, Bratislava - scientific advisor Institute of Physiology 2011 - present
Slovak medical university - scientific researcher Dept.of clinical and experimental pharmacotherapy, SMU Bratislava 2006 - 2011
Hospital in Trnava - physician Department of neurology 2005-2006

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other IV.b - Name of the institution IV.c - Year
- SAIA (Slovenská akademická informačná agentúra): Uľahčenie vstupu doktorandom a mladým vedeckým pracovníkom do praxe SAIA 2007
General Course on Intellectual Property DL-101 WIPO (World Intellectual Property Organization) 2008
Legislatívne povinnosti vedúcich projektov pri práci s laboratórnymi zvieratami podľa zákona č. 23/2009 Slovak Medical University 2010
Patent Information Search DL-318E WIPO (World Intellectual Property Organization) 2010

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.2 - Number of defended theses
V.5 - Overview of other courses taught in the current academic year according to study programmes
V.5.a - Name of the course V.5.b - Study programme V.5.c - Degree V.5.d - Field of study
Biomedical physics Biomedical physics Biomedical physics

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
36
VI.1.b - Over the last six years
2
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
14
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
239
VI.1.b - Over the last six years
104
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
239
VI.1.b - Over the last six years
104
VI.1.5 - Number of invited lectures at the international, national level
VI.1.a - Overall
2
VI.2 - The most significant research/artistic/other outputs
1

Šebeková, K., Dušinská, M., Simon Klenovics, K., ...Marcomini, A., Volkovová, K.: Comprehensive assessment of nephrotoxicity of intravenously administered sodium-oleate-coated ultra-small superparamagnetic iron oxide (USPIO) and titanium dioxide (TiO2) nanoparticles in rats. Nanotoxicology 2014, 8(2), pp. 142–157, (IF 7,336, Q1)

2

Boor, P., Celec, P., Martin, I.V., ...Heidland, A., Šebeková, K.: The peroxisome proliferator-activated receptor-α agonist, BAY PP1, attenuates renal fibrosis in rats. Kidney International 2011, 80(11), pp. 1182–1197, (IF 6,105, Q1)

3

Palkovits, M., Šebeková, K., Klenovics, K.S., ...Bahner, U., Heidland, A.: Neuronal Activation in the Central Nervous System of Rats in the Initial Stage of Chronic Kidney Disease-Modulatory Effects of Losartan and Moxonidine. PLoS ONE 2013, 8(6), e66543 , (IF 3,730, Q1)



4

Klenovics, K.S., Boor, P., Somoza, V., ...Fogliano, V., Šebeková, K.: Advanced Glycation End Products in Infant Formulas Do Not Contribute to Insulin Resistance Associated with Their Consumption. PLoS ONE 2013, 8(1), e53056, (IF 3,730, Q1)

5

Simon Klenovics, K., Kollárová, R., Hodosy, J., Celec, P., Šebeková, K.: Reference values of skin autofluorescence as an estimation of tissue accumulation of advanced glycation end products in a general Slovak population. Diabetic Medicine 2014, 31(5), pp. 581–585, (IF 3,064, Q2)

VI.3 - The most significant research/artistic/other outputs over the last six years
VI.4 - The most significant citations corresponding to the research/artistic/other outputs
1

Arabi, T., Shafqat, A., Sabbah, B.N., Fawzy, N.A.Shah, H..Abdulkader, H., Razak, A., Sabbah, A.N., Arabi, Z.: Obesity-related kidney disease: Beyond hypertension and insulin-resistance. Frontiers in endocrinology 2023, 13, 1095211

2

Li, Ke, Zhao, Jing, Wang, Mingxuan, Niu, Lingzhi, Wang, Yuanping, Li, Yanxia, Zheng, Yajuan: The roles of various prostaglandins in fibrosis: A review. Biomolecules 2021, 11(6),789.

3

Uchiyama, Mayara Ka; Hebeda, Cristina Bb; Sandri, Silvanab; Paula-Silva, Marina Deb;Sandra Hpb  Romano, Marianaa; Cardoso, Roberta Ma; Toma, Sergio Ha; Araki, Koitia, , Farsky: In vivo evaluation of toxicity and anti-inflammatory activity of iron oxide nanoparticles conjugated with ibuprofen. Nanomedicine 2021, 16, 9, 741-758.

4

Liu, Yongminga;Yu, Huana;Zhang, Xihuia;Wang, Yonga;Song, Zhentaob;Zhao, Jianb; Shi, Haibina;Li, Ruibina;Wang, Yangyuna, Zhang, Leshuai W.a : The protective role of autophagy in nephrotoxicity induced by bismuth nanoparticles through AMPK/mTOR pathway. Nanotoxicology 2018, 12, 6, 586 – 601.

5

Korpijaakko, Cedrica, Wasenius, Nikoa, b; Teramo, Karic; Klemetti, Miira M.c, d, e; Kautiainen, Hannua, b, f;Eriksson, Johan G.a, b, g, h; Laine, Merja K.a, b : Skin Autofluorescence in Young Adult Offspring of Women with Type 1 Diabetes:                                                                     A Cross-Sectional Case–Control Study. Diabetes Therapy 2021, 12, 3, 669 – 677.

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

IX. - Other relevant facts